Pharmacogenomics Technology Market Size, Share & Trends Report

Pharmacogenomics Technology Market Size, Share & Trends Analysis Report By Therapeutic Area, By Technology (PCR, In-situ Hybridization, Immunohistochemistry, Sequencing, Others), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-940-1
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Market Segmentation

  • Pharmacogenomics Technology Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    • Oncology
      • Lung Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Others
    • Neurological Disorders
    • Cardiovascular Disease
    • Immunological Disorders
    • Infectious Diseases
    • Others
  • Pharmacogenomics Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • PCR
    • In-situ Hybridization
    • Immunohistochemistry
    • Sequencing
    • Others
  • Pharmacogenomics Technology Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Infectious Diseases
        • Others
      • North America Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • U.S.
        • U.S. Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        •  U.S. Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Canada
        • Canada Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Canada Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
    • Europe
      • Europe Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Infectious Diseases
        • Others
      • Europe Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • U.K.
        • U.K. Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • U.K. Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Germany
        • Germany Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Germany Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • France
        • France Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • France Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Italy
        • Italy Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Italy Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Spain
        • Spain Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Spain Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Sweden
        • Sweden Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Sweden Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Norway
        • Norway Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Norway Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Denmark
        • Denmark Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Denmark Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
    • Asia Pacific
      • Asia Pacific Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Infectious Diseases
        • Others
      • Asia Pacific Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • Japan
        • Japan Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Japan Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • China
        • China Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • China Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • India
        • India Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • India Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Australia
        • Australia Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Australia Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Thailand
        • Thailand Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Thailand Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • South Korea
        • South Korea Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • South Korea Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
    • Latin America
      • Latin America Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Infectious Diseases
        • Others
      • Latin America Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • Brazil
        • Brazil Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Brazil Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Mexico
        • Mexico Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Mexico Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Argentina
        • Argentina Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Argentina Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
    • Middle East and Africa
      • Middle East and Africa Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Infectious Diseases
        • Others
      • Middle East and Africa Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • Saudi Arabia
        • Saudi Arabia Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Saudi Arabia Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • South Africa
        • South Africa Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • South Africa Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • UAE
        • UAE Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • UAE Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Kuwait
        • Kuwait Pharmacogenomics Technology Market, Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Infectious Diseases
          • Others
        • Kuwait Pharmacogenomics Technology Market, Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon